<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interstitial loss of <z:hpo ids='HP_0000001'>all</z:hpo> or part of the long arm of chromosome 5, or del(5q), is a frequent clonal chromosomal abnormality in human <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, a preleukemic disorder) and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), and is thought to contribute to the pathogenesis of these diseases by deleting one or more <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor genes </plain></SENT>
<SENT sid="1" pm="."><plain>Although a major commonly deleted region (CDR) has been delineated on chromosome band 5q31.1 (refs </plain></SENT>
<SENT sid="2" pm="."><plain>3-7), attempts to identify <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors within this band have been unsuccessful </plain></SENT>
<SENT sid="3" pm="."><plain>We focused our analysis of gene expression on <z:chebi fb="40" ids="33697">RNA</z:chebi> from primitive <z:hpo ids='HP_0001909'>leukemia</z:hpo>-initiating cells, which harbor 5q deletions, and analyzed 12 genes within the CDR that are expressed by <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoietic stem cells </plain></SENT>
<SENT sid="4" pm="."><plain>Here we show that the gene encoding alpha-catenin (CTNNA1) is expressed at a much lower level in <z:hpo ids='HP_0001909'>leukemia</z:hpo>-initiating stem cells from individuals with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with a 5q deletion than in individuals with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> lacking a 5q deletion or in <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoietic stem cells </plain></SENT>
<SENT sid="5" pm="."><plain>Analysis of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells, a myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> line with deletion of the 5q31 region, showed that the CTNNA1 promoter of the retained allele is suppressed by both methylation and <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylation </plain></SENT>
<SENT sid="6" pm="."><plain>Restoration of CTNNA1 expression in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells resulted in reduced proliferation and apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, loss of expression of the alpha-catenin <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in hematopoietic stem cells may provide a growth advantage that contributes to human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with del(5q) </plain></SENT>
</text></document>